A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MS / maternal serum

[Related PubMed/MEDLINE]
Total Number of Papers: 69
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MS  (>> Co-occurring Abbreviation)
Long Form:   maternal serum
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Concentrations of bisphenol A and its alternatives in paired maternal-fetal urine, serum and amniotic fluid from an e-waste dismantling area in China. AF, AF, BPA, BPAF, BPS, CS, GM, MU, MU
2019 Associations between the Level of Trace Elements and Minerals and Folate in Maternal Serum and Amniotic Fluid and Congenital Abnormalities. AF
2019 Evaluation of Essential and Toxic Elements in Amniotic Fluid and Maternal Serum at Birth. AF, ICP-MS
2019 Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). ACMG, AFP, ONTDs, OSB
2019 Maternal Serum, an Isolation and Expansion Tool for Umbilical Cord Matrix Mesenchymal Stromal Cells. MSCs
2018 Distribution of Phthalate Metabolites between Paired Maternal-Fetal Samples. AF, CS, MU, PAEs
2018 Lactoferrin level in maternal serum is related to birth anthropometry - an evidence for an indirect biomarker of intrauterine homeostasis? ANOVA, BW, HC
2016 Ultrasound and endocrinological markers of first trimester placentation and subsequent fetal size. AFP, fbeta-hCG, PAPP-A, SGA
2014 Study of the concentration of trace elements fe, zn, cu, se and their correlation in maternal serum, cord serum and colostrums. CS
10  2013 2D-Ultrasound and endocrinologic evaluation of placentation in early pregnancy and its relationship to fetal birthweight in normal pregnancies and pre-eclampsia. PE, PTD
11  2013 Evaluation of the impact of maternal smoking on ultrasound and endocrinological markers of first trimester placentation. AFP, fbeta-hCG, PAPP-A
12  2013 Organochlorine pesticide residues in biological compartments of healthy mothers. Adp T, BM, DDD, DDT, OCPs
13  2012 The soluble receptor for advanced glycation end products can prospectively identify patients at greatest risk for preterm birth. AUC, CS, PTB, PTL, sRAGE
14  2011 Autism spectrum disorders and maternal serum alpha-fetoprotein levels during pregnancy. AFP, ASD
15  2011 Soluble Flt-1 and PlGF: new markers of early pregnancy loss? PlGF, TM, VEGF
16  2010 Immune response parameters during labor and early neonatal life. UC
17  2009 Potential function of amniotic fluid in fetal development---novel insights by comparing the composition of human amniotic fluid with umbilical cord and maternal serum at mid and late gestation. AF, UCS
18  2009 The impact of fetal gender on first trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A MoM in normal and trisomy 21 pregnancies. beta-hCG
19  2007 Tumor markers in biological fluids associated with pregnancy. AF, AFP, CA 15-3, CA125, CA19-9, CEA, hCG, MCA, PSA, SCC, TPS, UC
20  2006 Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia. AF, ELISA
21  2006 Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life. UC
22  2005 Maternal serum and umbilical cord tumor marker levels at term pregnancy. CA, CA, CEA, UC
23  2005 Necessity to measure PCBs and organochlorine pesticide concentrations in human umbilical cords for fetal exposure assessment. CS, UC
24  2004 Age-related differentiations of Th1/Th2 cytokines in newborn infants. IFN-gamma, IL-2, IL-4, UC
25  2003 Concentrations of soluble Fas in maternal serum and amniotic fluid during uncomplicated pregnancies. AF, sFas
26  2003 Indicative markers of cell proliferation and apoptosis during the perinatal period. CS, sFas, TPS, UC
27  2003 Soluble Fas antigen and soluble Fas ligand in early neonatal life. sFas, sFasL, UC
28  2002 Antibodies against oxidized low density lipoproteins in pregnant women. ACA, oxLDL
29  2002 Macrophage migration inhibitory factor in human pregnancy and labor. AF, CS, ELISA, MIF
30  2002 Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. AF, BPA
31  2002 Mucin-like carcinoma-associated antigen in paired serum and breast milk samples of lactating mothers and sera of their neonates in the early postpartum period. ---
32  2001 Mucin-like carcinoma-associated antigen (MCA) during normal pregnancy. AF, MCA
33  2000 Expression of pro-EPIL peptides encoded by the insulin-like 4 (INSL4) gene in chromosomally abnormal pregnancies. AF, EPIL, hCG, INSL4
34  2000 Tissue polypeptide specific antigen (TPS) throughout normal pregnancy. AF, TPS
35  2000 [Insulin-like growth factor-I(IGF-I), and its binding protein-3 (IGFBP-3) correlated with fetal development]. BW, GDM, IGF-I, MNDP, NP, UCS
36  1999 Breast cancer markers during normal pregnancy. AF
37  1999 Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies. hCG, MOM
38  1999 Patterns of inflammatory cytokine serum concentrations during the perinatal period. IL-1beta, IL-6, TNF-alpha, UC
39  1999 The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, and CEA. AF, CEA
40  1999 Ultrarapid cryopreservation of human embryos: experience with 1,582 embryos. Suc, URF
41  1998 Inflammatory cytokines in newborn infants. UC
42  1998 Maternal serum alpha-fetoprotein in fetal anal atresia and other gastro-intestinal obstructions. AFP, GI
43  1998 Measurement of CA 72.4 in maternal serum and amniotic fluid. AF
44  1997 Dimeric inhibins in amniotic fluid, maternal serum, and fetal serum in human pregnancy. AF
45  1997 Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. AF, CM, EEC, IGFBP-1, IGFs
46  1996 Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. ---
47  1996 Clinical experience with synthetic serum substitute as a protein supplement in IVF culture media: a retrospective study. PL, SSS
48  1996 Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. AF, AFP, CNF, MoM
49  1995 Fibroblast growth factor-2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. AF, AGA, CS, FGF-2
50  1994 Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. AF, EEC, IGFBPs, IGFs
51  1994 Placental production of human chorionic gonadotrophin alpha and beta subunits in early pregnancy as evidenced in fluid from the exocoelomic cavity. ECF, hCG
52  1993 Human chorionic gonadotropin pattern in maternal circulation. Amniotic fluid and fetal circulation in late pregnancy. AF, FS, hCG
53  1992 Amniotic fluid hormone profiles during normal and abnormal pregnancy. AF, AFP, Et, PRL, SP1
54  1992 Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy. AF, CA125, CEA, SCC, UCB
55  1992 Glucose, insulin, HGH and IGF-I levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. AF, IUGR, UV
56  1992 High levels of maternal serum alpha-fetoprotein and human chorionic gonadotrophins leading to the diagnosis of combined neural tube defect and partial mole. AFP, hCG
57  1992 Human chorionic gonadotrophin and subunit composition of maternal serum and coelomic and amniotic fluids in the first trimester of pregnancy. AF, EECF, hCG
58  1992 Relatively reduced values of plasma alpha-fetoprotein at early second trimester of pregnancies with hypertensive disorders. AFP
59  1992 Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies. MoM, SP1
60  1991 Estimating the risk of a fetal autosomal trisomy at mid-trimester using maternal serum alpha-fetoprotein and age: a retrospective study of 142 pregnancies. AFP, MOM
61  1991 First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome. AFP, DS, MoM
62  1990 Second-trimester levels of maternal serum unconjugated oestriol and human chorionic gonadotropin in pregnancies affected by fetal anencephaly and open spina bifida. hCG, MoM
63  1988 Amniotic fluid-AFP in Down syndrome and other chromosome abnormalities. AF, AFP
64  1988 Significance of IgE level in amniotic fluid and cord blood for the prediction of allergy. AF, CS
65  1988 [Beta-HCG concentration in maternal serum and in amniotic fluid of patients in labor with physiologic pregnancies]. AF
66  1986 Factors influencing murine embryo bioassay: effects of proteins, aging of medium, and surgical glove coatings. BSA, FCS, HPLC, IVF, SC, SDS-PAGE, TC, UL
67  1983 Effect of metoclopramide on maternal and fetal hyperprolactinemia. CB, MET
68  1981 Alpha-fetoprotein: a review. AF, AFP
69  1976 Maternal serum and amniotic fluid alpha-fetoprotein as a marker of acute fetal distress in a midtrimester abortion model. AF, alpha-FP, IAT, PGF2 alpha